ClinicalTrials.gov
public full text
Public Domain
Prevalence of Regular Gynecological Follow-up Among Women of Childbearing Age
The French National Authority for Health (Haute Autorité de Santé, HAS) recommends regular gynecological follow-up, specifying that it is considered regular when it is annual. The objectives of this gynecological follow-up are multiple: to support women in the choice and management of contraception as well as in their sexuality; to screen for cervical cancer and breast cancer; to diagnose and to take care of sexually transmitted infections (STIs); and to diagnose and treat gynecological conditions such as adenomyosis, endometriosis, polycystic ovary syndrome, etc. Regarding cervical cancer screening, the HAS recommends performing a Pap smear (cervical cytology) starting at the age of 25 and up to the age of 65. Several studies, such as those by Henry et al. in 2020 and Owokuhaisa et al. in 2024, have identified major barriers to access to gynecological care for women. These barriers include very long waiting times, lack of privacy, lack of understanding or access to appropriate information, discomfort or fear during consultations, shortage of physicians, past negative experiences, etc. These factors may contribute to women postponing or even forgoing their gynecological consultations. A study by Landy et al. in 2021 also showed that women diagnosed with advanced-stage cervical cancer had not undergone regular screening or gynecological follow-up.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Improving Access to Cervical Cancer Screening#1378276
- Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana#855493
- Risk of Cervical Precancer and Cancer Among HIV-Infected Women With Normal Cervical Cytology and No Evidence of Oncogenic HPV Infection#1133011
- Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease#836223
- Low-Cost Molecular Cervical Cancer Screening Study#801340
Record · ID 1439828
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive